Hype to Reality: True Potential of GenAI in Private Equity

Share:

Overview

Body

Generative AI rapidly revolutionized the market, prompting companies to integrate this technology and spawning numerous startups. However, the gap between hype and reality raises questions about GenAI's true potential and ROI.  In this session, we'll explore  real-world applications of GenAI in Private Equity and beyond. Haley Altman, a former M&A attorney with extensive GenAI experience, and Anthony Bahr, Managing Director of Strategex's PE Practice, will examine GenAI's possibilities in transactions, managing risk in technology investments, evaluating AI solutions, and key ROI metrics.

Hosted by: ACG
Chapter
Chicago
Share: